Home > Healthcare > Medical Devices > Diagnostic Devices > Diagnostic Ultrasound Market
Diagnostic ultrasound market value from the 2D technology segment was worth more than USD 2 billion in 2022, owing to the extensive product availability and affordability. 2D ultrasound is gaining ground as a gold standard for gestational care. There has also been a significant rise in pregnancy complications following the coronavirus outbreak. Such a trend will bolster the use of effective 2D ultrasound machines to monitor the ovaries and uterus during pregnancy. Additionally, the improved image quality and the delivery of reliable and fast outcomes will amplify the adoption of 2D ultrasound procedures.
In terms of portability, the diagnostic ultrasound market from trolley segment accounted for over 65.5% share of the diagnostic ultrasound industry in 2022, on account of the portable nature, making them easy to relocate across the healthcare facility. This enables professionals to diagnose severely ill and bedridden patients conveniently at their bedside, without affecting the quality of the treatment. Additionally, trolley-based devices are more economical than traditional ultrasound devices. This enables small public clinics, specialists, and general physicians to purchase separate devices according to their specific requirements, further bolstering product consumption.
Diagnostic ultrasound market share from the obstetrics/gynecology application segment is slated to depict over 4% CAGR from 2023 to 2032. This is driven by the mounting product adoption to monitor pregnancy and fetal wellbeing. Ultrasound examinations can also help view organs from different orientations. These attributes, alongside the rapid advancement in 4D and 3D imaging and transvaginal sonography, will add impetus to diagnostic ultrasound equipment development for obstetrics/gynecology applications.
Based on end-use, the diagnostic ultrasound market size from the maternity centers segment reached USD 1.5 billion in 2022, due to the rising number of births in developed nations. According to data from the CDC, in 2021, the general fertility and birth rates increased for the first time in seven years, registering over 3,659,289 births. These factors, alongside the high availability of ultrasound services in developing nations, will augment product adoption across maternity centers over the forecast period.
North America held over 30.5% share of the diagnostic ultrasound market in 2022, as a result of the high prevalence of chronic diseases. As per statistics from the CDC, 6 in 10 Americans live with at least a chronic disease such as stroke, cancer, and diabetes. Over the years, R&D projects and spending related to healthcare have also surged. In addition, the emphasis on diagnostic system innovation will assert a positive influence on the production of diagnostic ultrasound systems across North America in the upcoming years.